US Patent Issued to Sanegene Bio USA on May 26 for "5'-modified carbocyclic ribonucleotide derivatives and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,301, issued on May 26, was assigned to Sanegene Bio USA Inc. (Woburn, Mass.).

"5'-modified carbocyclic ribonucleotide derivatives and methods of use" was invented by Weimin Wang (Winchester, Mass.) and Xiaochuan Cai (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides phosphate mimic derivatives of Formula (I) or (II):pharmaceutically acceptable salts thereof, and related Nucleic Acid Agents and conjugates. The present disclosure also relates to uses of the phosphate mimic derivatives (e.g., in the Nucleic Acid Agents and conjugates) in treating or preventing diseases."

The patent was filed on Feb. 22, 202...